Case 2:20-cv-00337-JRG Document 224 Filed 11/11/21 Page 1 of 6 PageID #: 8492
`
`SEAGEN INC.,
`
`
`
`
`v.
`
`Plaintiff,
`
`
`
`
`
`CASE NO. 2:20-cv-00337-JRG
`
`
`
`
`
`IN THE UNITED STATES DISTRICT COURT
`EASTERN DISTRICT OF TEXAS
`MARSHALL DIVISION
`
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`
`
`DAIICHI SANKYO CO., LTD.,
`
`
`Defendant, and
`
`
`ASTRAZENECA PHARMACEUTICALS
`LP and ASTRAZENECA UK LTD.,
`
`
`Intervenor-Defendants.
`
`
`
`
`
`
`
`UNOPPOSED MOTION TO WITHDRAW MOTIONS TO COMPEL
`REGARDING PRIVILEGE ISSUES [DKT. 201, 202, 211]
`
`
`
`SEAGEN INC.,
`
`
`
`
`v.
`
`Plaintiff,
`
`
`
`
`
`CASE NO. 2:20-cv-00337-JRG
`
`
`
`
`
`IN THE UNITED STATES DISTRICT COURT
`EASTERN DISTRICT OF TEXAS
`MARSHALL DIVISION
`
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`
`
`DAIICHI SANKYO CO., LTD.,
`
`
`Defendant, and
`
`
`ASTRAZENECA PHARMACEUTICALS
`LP and ASTRAZENECA UK LTD.,
`
`
`Intervenor-Defendants.
`
`
`
`
`
`
`
`UNOPPOSED MOTION TO WITHDRAW MOTIONS TO COMPEL
`REGARDING PRIVILEGE ISSUES [DKT. 201, 202, 211]
`
`
`
`Case 2:20-cv-00337-JRG Document 224 Filed 11/11/21 Page 2 of 6 PageID #: 8493
`
`
`
`Plaintiff Seagen Inc. (“Seagen”), Defendant Daiichi Sankyo Co. Ltd. (“Daiichi Sankyo
`
`Japan”), and Defendant-Intervenors AstraZeneca Pharmaceuticals LP and AstraZeneca UK Ltd.
`
`(collectively, “AstraZeneca”) have reached agreement as to the various disputes raised in their
`
`Motions to Compel (Dkt. 201, 202, 211) (“Motions”) regarding privilege as follows:
`
`I.
`
`AstraZeneca’s Intentional Privilege Waiver [Dkt. 201]
`
`AstraZeneca agrees to produce, by November 12, 2021, the following:
`
`1. The September 17, 2020 Opinion Letter by Capuano IP listed as Priv-001 on
`
`AstraZeneca’s Privilege Log;
`
`2. Drafts (if any) of Priv-001 that were sent to AstraZeneca;
`
`3. Communications (including emails) between AstraZeneca and Capuano IP regarding
`
`Priv-001;
`
`4. Documents relating to AstraZeneca’s tracking, prior to July 17, 2020, of the ‘839
`
`application (if any);
`
`5. The email listed as Priv-002 on AstraZeneca’s Privilege Log
`
`The parties agree that this resolves their dispute as to the scope of AstraZeneca’s intentional
`
`privilege waiver and Seagen agrees it will not argue that AstraZeneca’s previous production of
`
`any privileged materials or any of the materials listed above results in a broader waiver of privilege.
`
`Consistent with 35 U.S.C. § 298, Seagen agrees that it will not use, rely upon, or reference
`
`at trial the fact that Daiichi Sankyo Japan has not produced or relied upon any opinion of counsel
`
`it may have obtained.
`
`II.
`
`Common Interest Privilege [Dkt. 201 and 202]
`
`Daiichi Sankyo Co. Ltd. (“Daiichi Sankyo Japan”) and Defendant-Intervenors
`
`AstraZeneca Pharmaceuticals LP and AstraZeneca UK Ltd. (collectively, “AstraZeneca”) agree to
`
`provide a privilege log as to communications (if any) between them prior to July 17, 2020 as to:
`
`
`
`Case 2:20-cv-00337-JRG Document 224 Filed 11/11/21 Page 3 of 6 PageID #: 8494
`
`
`
`(1) the ‘039 Patent; (2) the ‘839 application; or (3) any of the earlier applications to which the ‘039
`
`Patent claims priority.
`
`III. Dr. Toki’s Deposition Testimony [Dkt. 211]
`
`1. The parties agree that the question and answer reflected in Dr. Toki’s deposition at
`
`pages 277:23-278:13 will be withdrawn and no party may use, refer, or rely upon that
`
`deposition testimony at any point.
`
`2. Defendants shall be permitted to inquire, without any privilege objection by Seagen,
`
`about the personal knowledge of any of the named inventors on the ‘039 Patent as to
`
`what was or was not included in any of the applications to which the ‘039 Patent claims
`
`priority and why.
`
`3. Seagen is permitted to object on the basis of privilege to the extent any questioning
`
`seeks to elicit testimony about the contents of any discussions with legal counsel about
`
`what to include or not include in the applications.
`
`* * *
`
`
`
`In light of and in reliance on the foregoing agreements, Seagen respectfully requests leave
`
`to withdraw its motions to compel against AstraZeneca and Daiichi Sankyo Japan (Dkt. 201 and
`
`202) and AstraZeneca respectfully requests leave to withdraw its motion to compel against Seagen
`
`(Dkt. 211).
`
`
`
`
`
`
`
`
`
`2
`
`
`
`Case 2:20-cv-00337-JRG Document 224 Filed 11/11/21 Page 4 of 6 PageID #: 8495
`
`
`
`
`
`By: /s/ Deron R. Dacus
` (with permission by
` Jennifer P. Ainsworth)
` Deron R. Dacus
`Texas State Bar No. 00790553
`ddacus@dacusfirm.com
`THE DACUS FIRM, P.C.
`821 ESE Loop 323, Suite 430
`Tyler, Texas 75701
`Telephone: 903.705.1117
`Facsimile: 903.581.2543
`
`J. Mark Mann
`Texas State Bar No. 12926150
`mark@themannfirm.com
`G. Blake Thompson
`Texas State Bar No. 240420033
`blake@themannfirm.com
`MANN | TINDEL | THOMPSON
`201 E. Howard Street
`Henderson, Texas
`Telephone: 903.357.8540
`Facsimile: 903.657.6003
`
`Attorneys for Defendant Daiichi Sankyo
`Company, Limited
`
`OF COUNSEL:
`Preston K. Ratliff II
`Joseph M. O’Malley, Jr.
`Ashley N. Mays-Williams
`PAUL HASTINGS LLP
`200 Park Avenue
`New York, New York 10166
`Telephone: 212.318.6000
`
`
`
`3
`
`Dated: November 11, 2021
`
`Respectfully Submitted,
`
`By: /s/ Matthew A. Chivvis
` (with permission by
` Jennifer P. Ainsworth)
`Michael A. Jacobs
`MJacobs@mofo.com
`Matthew A. Chivvis
`MChivvis@mofo.com
`MORRISON & FOERSTER LLP
`425 Market Street
`San Francisco, California 94105
`Telephone: 415.268.7000
`Facsimile: 415.268.7522
`
`Bryan Wilson
`BWilson@mofo.com
`Pieter S. de Ganon
`PdeGanon@mofo.com
`MORRISON & FOERSTER LLP
`755 Page Mill Road
`Palo Alto, California 94304-1018
`Telephone: 650.813.5600
`Facsimile: 650.494.0792
`
`Melissa R. Smith
`Texas State Bar No. 24001351
`melissa@gillamsmithlaw.com
`GILLAM & SMITH, LLP
`303 South Washington Avenue
`Marshall, Texas 75670
`Telephone: 903.934.8450
`Facsimile: 903.934.9257
`
`Of Counsel:
`
`T. John Ward, Jr.
`Texas State Bar No. 00794818
`jw@wsfirm.com
`Charles Everingham IV
`Texas State Bar No. 00787447
`ce@wsfirm.com
`
`
`
`
`
`
`
`Case 2:20-cv-00337-JRG Document 224 Filed 11/11/21 Page 5 of 6 PageID #: 8496
`
`Andrea L. Fair
`Texas State Bar No. 24078488
`andrea@wsfirm.com
`WARD, SMITH & HILL, PLLC
`1507 Bill Owens Parkway
`Longview, Texas 75604
`Telephone: 903.757.6400
`Facsimile: 903.757.2323
`
`Attorneys for Plaintiff Seagen Inc.
`
`
`
`Jeffrey A. Pade
`PAUL HASTINGS LLP
`2050 M Street NW
`Washington, DC 20036
`Telephone: 202.551.1700
`
`Attorneys for Defendant Daiichi Sankyo
`Company, Limited
`
`
`By: /s/ Jennifer Parker Ainsworth
`Jennifer Parker Ainsworth
`Texas State Bar No. 00784720
`WILSON, ROBERTSON
` & CORNELIUS, P.C.
`909 ESE Loop 323, Suite 400
`Tyler, Texas 75701
`Telephone: 903.509.5000
`Facsimile: 903.509.5092
`
`
`
`David I. Berl
`Thomas S. Fletcher
`Jessica L. Pahl
`Kathryn Kayali
`Kevin Hoagland-Hanson
`Andrew Hoffman
`WILLIAMS & CONNOLLY LLP
`725 Twelfth Street, N.W.
`Washington, DC 20005
`Telephone: 202.434.5000
`Facsimile: 202.434.5029
`
`Attorneys for Intervenor-Defendants
`AstraZeneca Pharmaceuticals LP and
`AstraZeneca UK Ltd.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`4
`
`
`
`Case 2:20-cv-00337-JRG Document 224 Filed 11/11/21 Page 6 of 6 PageID #: 8497
`
`
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that counsel of record who are deemed to have consented to electronic
`
`service are being served this 11th day of November 2021, with a copy of this document via the
`
`Court’s CM/ECF system per Local Rule CV-5(a)(3).
`
`/s/ Jennifer P. Ainsworth
`Jennifer P. Ainsworth
`
`
`
`
`
`
`
`CERTIFICATE OF CONFERENCE
`
`I hereby certify that counsel for Plaintiff and counsel for Defendants have complied with
`
`the meet and confer requirement in Local Rule CV -7(h) regarding this motion on November 11,
`
`2021. The Parties are jointly filing this motion.
`
`/s/ Jennifer P. Ainsworth
`Jennifer P. Ainsworth
`
`
`
`
`
`
`
`5
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
